About

About GekkoVet

GekkoVet was founded in Helsinki, Finland with a single premise: veterinary clinical decision support should be built on structured, peer-reviewed evidence — not on probabilistic AI outputs.

Over 8 years, our veterinary team has created a clinical knowledge base covering approximately 1,000 conditions and 37,000+ symptom-diagnosis combinations. Its core is a unique and proprietary dataset that has been validated against scientific literature of more than 80,000 pages of peer-reviewed medical references. Every entry is validated by practising DVMs and pharmacists.

Today, GekkoVet serves as the clinical intelligence layer for veterinary platforms and insurers — providing the structured veterinary knowledge that these organisations need but cannot build on their own timelines.

Team

AV

Anne Varjo

CVO & Co-Founder

DVM and pharmacist. Owns all clinical content and the veterinary knowledge architecture.

PO

Pertti Orakoski

CEO & Co-Founder

Business leadership and strategic direction.

JM

Johanna Majamaa

CMO & Co-Founder

DVM. Architect of the diagnostic framework and clinical workflows.

JJ

Jukka Jyräsalo

CLO/CFO & Co-Founder

Legal and financial oversight.

YP

Yves Prevoo

CCO

DVM, MBA. Commercial strategy and partnership development.

NN

Niklas Närhinen

CTO

Platform engineering and API architecture. Responsible for the technical infrastructure.

HH

Heidi Hermiö

Veterinary Research Specialist

Primary creator and validator of the clinical knowledge base.

MO

Mailis Orakoski

Marketing & Communications

Marketing and communications strategy.

The knowledge base

The GekkoVet clinical knowledge base is the core asset of the company. It is not a dataset scraped from the internet or generated by a language model. It is a structured, validated body of veterinary clinical knowledge built by veterinary professionals over 8 years.

Sources include peer-reviewed veterinary journals, pharmacology databases, and specialist clinical references. Every symptom-diagnosis relationship, drug dosing recommendation, and treatment protocol has been reviewed and validated by DVMs and pharmacists with direct clinical experience.

The knowledge base is continuously maintained. New conditions, updated treatment guidelines, and revised drug information are added on an ongoing basis by the veterinary research team.